What's in Aivita Biomedical, Inc.'s pipeline?

Aivita Biomedical, Inc. has 5 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Aivita Biomedical, Inc.'s portfolio?

Top competitors by shared drug class: Bone Therapeutics S.A, BriaCell Therapeutics Corporation, Capricor Inc., EHL Bio Co., Ltd., Gamida Cell ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aivita-biomedical-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Aivita Biomedical, Inc. — Portfolio Competitive Intelligence Brief

Aivita Biomedical, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
MC	MC	marketed	Mesenchymal stem cell therapy	Regenerative Medicine / Tissue Repair
AV-GBM-1	AV-GBM-1	phase 3	Autologous dendritic cell vaccine	Oncology
Autologous monocytes	Autologous monocytes	phase 3	Cell therapy; autologous cellular immunotherapy	Immunology; Regenerative Medicine

Therapeutic area mix

Immunology; Regenerative Medicine · 1
Oncology · 1
Regenerative Medicine / Immunology · 1
Regenerative Medicine / Tissue Repair · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bone Therapeutics S.A · 1 shared drug class
BriaCell Therapeutics Corporation · 1 shared drug class
Capricor Inc. · 1 shared drug class
EHL Bio Co., Ltd. · 1 shared drug class
Gamida Cell ltd · 1 shared drug class
Mesoblast, Inc. · 1 shared drug class
University of Missouri-Columbia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Aivita Biomedical, Inc.:

Cite this brief

Drug Landscape (2026). Aivita Biomedical, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aivita-biomedical-inc. Accessed 2026-05-16.